Beasley Allen lawyer Danielle Ward Mason has been appointed to serve on the Plaintiffs’ Steering Committee (PSC) for the consolidated multidistrict litigation (MDL) pending in New Jersey federal court concerning Invokana’s link to kidney damage and diabetic ketoacidosis.
Invokana is a prescription medication used to treat Type 2 Diabetes. One of a number of serious side effects associated with the drug, diabetic ketoacidosis (DKA) is a type of acidosis that develops when insulin levels are too low or during prolonged fasting. Complications of DKA include difficulty breathing, nausea, vomiting, abdominal pain, confusion and unusual fatigue or sleepiness. The condition can result in a diabetic coma, extended hospitalization and even death.
The lawsuits allege Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to properly test the Type 2 diabetes drug and warn consumers, health care professionals and the medical community of the risks and consequences of using it. The Judicial Panel on Multidistrict Litigation appointed U.S. District Judge Brian R. Martinotti to preside over the MDL, which consolidated 55 cases filed in federal courts across the country. Consolidating the cases into a MDL allows the PSC to put more pressure and focus on moving the case forward.
Danielle is Beasley Allen’s lead lawyer for Invokana litigation and has been with the firm since 2009. In 2015, she was named a Principal in the firm, becoming the first African-American woman at the firm to achieve that status. In addition to her work with Invokana, Danielle has handled cases involving Reglan and is on the Talcum Powder Litigation team.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.